Cromos Pharma Names New Head of Feasibility and Therapeutic Strategy
Cromos Pharma is delighted to welcome Bulgun Margaeva to our team. Bulgun takes up the role of Head of Feasibility and Therapeutic Strategy. Skilled Clinical Research Professional Bulgun is a well-recognized specialist with over 15 years of experience in pharmaceutical industry including work at AstraZeneca, Amgen, Novartis and Roche. She gradually ascended to leadership positions, where she
Meet Cromos Pharma at the ASCO Annual Meeting 2022
We at Cromos Pharma are looking forward to learning about the latest advances in oncology research at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO) that will take place on June 3-7 in Chicago, IL. Vlad Bogin, Cromos Pharma’s CEO will be attending. Meet him in person or set up a virtual call by emailing bd@cromospharma.com.
Clinical Trials Disrupted During War in Ukraine
Ukraine is recognized as an attractive location for conducting clinical trials. In April there were listed nearly 400 studies in Ukraine by ClinicalTrials.gov. However, due to the continuing war in Ukraine and the sanctions against Russia drug manufacturers had to stop recruiting patients to existing trials and put the launch of new trials on hold.
